ADMS

Adamas Pharmaceuticals, Inc.
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

63 hedge funds and large institutions have $151M invested in Adamas Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 4 closing their positions.

Holders
63
Holders Change
+11
Holders Change %
+21.15%
% of All Funds
1.68%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
16
Increased
24
Reduced
11
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
BJ
51
BlackRock Japan
Japan
$38K +$38K +2,155 New
AIG
52
American International Group
New York
$32.1K
Citigroup
53
Citigroup
New York
$31K +$5.16K +298 +20%
UBS Group
54
UBS Group
Switzerland
$15K +$4.56K +258 +44%
TRCT
55
Tower Research Capital (TRC)
New York
$13K -$22.3K -1,253 -63%
DA
56
Denali Advisors
California
$2K
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$1.22K +$1.22K +70 New
Barclays
58
Barclays
United Kingdom
$1K -$1.72K -150 -63%
PNC Financial Services Group
59
PNC Financial Services Group
Pennsylvania
$1K -$1.94K -66 -66%
CSS
60
Cubist Systematic Strategies
Connecticut
-$302K -17,415 Closed
GS
61
Gagnon Securities
New York
-$216K -12,415 Closed
Goldman Sachs
62
Goldman Sachs
New York
-$201K -11,567 Closed